About the Galderma restylane portfolio RESTYLANE is the original non-animal stabilized hyaluronic acid filler with more than 25 years of achievements and more than 50 million treatments worldwide. RESTYLANE FAMILY IMPORTANT SAFETY INFORMATION Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), if you are allergic to lidocaine or gram-positive bacterial proteins used to produce hyaluronic acid, are prone to bleeding, or if you have a bleeding disorder. The safety of its use during pregnancy or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders, as these side effects can occur with hyaluronic acid fillers.
Tell your doctor if you are planning other cosmetic treatments (e.g., tell your doctor if you are taking medications that lower the body's immune response or affect bleeding, such as aspirin or warfarin), as these medications may increase the risk of bruising or bleeding at the site of the injection of gel. Use of these products at gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete. The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lumps, itching at the injection site, and impaired hand function. Serious but rare side effects include late-onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site.
The risk of an involuntary injection into a blood vessel is small, but it can occur and cause serious complications, which can be permanent, such as vision abnormalities, blindness, stroke, temporary crusting, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection. Sign up for the latest updates Follow us on social media for current news and patient stories You are about to leave the Nestle Skin Health global site. Are you sure you want to leave this page? Restylane is manufactured by Q-Med, a Swedish Galderma company.
Galderma, a pharmaceutical company with more than 6,000 employees worldwide, specializes in dermatology and operates in more than 100 countries.